Compare SCLXW & NHPAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
National Healthcare Properties Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Current Price
| Metric | SCLXW | NHPAP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 31 | 26 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | SCLXW | NHPAP |
|---|---|---|
| Price | $0.16 | $19.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.0K | N/A |
| Earning Date | 03-07-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,152,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.02 | N/A |
| 52 Week Low | $0.18 | N/A |
| 52 Week High | $0.18 | N/A |
| Indicator | SCLXW | NHPAP |
|---|---|---|
| Relative Strength Index (RSI) | 41.02 | 74.43 |
| Support Level | $0.17 | $19.26 |
| Resistance Level | $0.21 | $19.50 |
| Average True Range (ATR) | 0.03 | 0.26 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 30.64 | 86.13 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
National Healthcare Properties Inc is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing operating properties (SHOP) and outpatient medical facilities (OMF), located in the United States. The company has SHOPs and OMFs as two reportable business segments for management and internal financial reporting purposes. OMF consists of physicians' offices and examination rooms, hospitals, pharmacies, other facilities. SHOP consist of assisted living facilities, memory care facilities, Independent Living facilities. Majority of revenue is from OMFs segment.